Sign in

CIK 0001730463 · Non-accelerated filer<br>Smaller reporting company

Autolus Therapeutics plc

Sign in to watch
Ticker
AUTL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 20 3829 6230
Business address
THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
Former names
Autolus Therapeutics Ltd
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 424B3 Offering Prospectus
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. 424B3 Offering Prospectus
  8. 8-K Event Shareholder vote results
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 8-K Event Other events
  11. 424B3 Offering Prospectus
  12. 8-K Event Executive or director change
  13. EFFECT Other Notice of Effectiveness
  14. 424B3 Offering Prospectus
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. S-1 Offering Registration Statement
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 5 of 17 · 340 filings